GeminIQ Website Logo

Viewing BPTH free

Subscribe for full history, 50+ metrics, screener, watchlist...

BIO-PATH HOLDINGS, INC.

BPTH

Companies in Pharmaceutical Preparations

BIO-PATH HOLDINGS, INC. (BPTH) — SEC Financial Statements & Analysis

BIO-PATH HOLDINGS, INC. (BPTH) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Cash And Cash Equivalents At Carrying Value
--00114012-
Assets
Cash
0-----40123
Assets Current
Assets Current
11124352356
Prepaid Expense Current
00001101111
Other Assets Current
00022211122
Property Plant And Equipment Gross
-1111111111
Assets Noncurrent
Accumulated Depreciation Depletion And Amortizatio…
--1-1-1-1-1-1-1-1-1-1
Property Plant And Equipment Net
--000000000
Operating Lease Right Of Use Asset
-0000000000
Assets
11124352357
Accounts Payable Current
55321112001
Liabilities And Stockhold…
Notes Payable Current
1000-------
Accrued Liabilities Current
33422222111
Liabilities Current
Derivative Liabilities
00---------
Liabilities Current
99853334211
Operating Lease Liability Current
-0000000000
Warrants And Rights Outstanding
0000001111-
Operating Lease Liability Noncurrent
-------0000
Liabilities
99854444321
Preferred Stock Value
0-00-0-----
Common Stock Value
00000000000
Common Stock Shares Subscribed But Unissued
-0---------
Stockholders Equity
Additional Paid In Capital
118118118118118114114108108107106
Stockholders Equity
-8-8-7-30-11-3035
Retained Earnings Accumulated Deficit
-126-126-125-120-118-115-113-111-108-104-101
Liabilities And Stockholders Equity
11124352357
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
1010101010101010101010
Preferred Stock Shares Issued
00000000000
Preferred Stock Shares Outstanding
00000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
200200200200200200200200200200200
Common Stock Shares Issued
3737333329262727252316
Shares Outstanding
3737333329262727252316

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202633.33%33.33%----------
20255.56%-5.56%-16.67%-14.29%-57.14%-28.57%20.00%20.00%20.00%---
2024-3.88%-33.72%-39.15%-35.10%-42.38%-35.10%-31.11%28.89%-10.00%0.00%11.76%11.76%
2023----13.95%-13.95%44.19%1.96%7.84%-17.65%-33.87%-56.98%-67.42%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.07
0.08
0.09
0.45
1.15
0.86
1.67
0.43
1.60
3.54
4.39
Quick Ratio
0.02
0.02
0.03
0.35
0.82
0.70
1.58
0.26
1.26
3.07
3.64
Working Capital
-8.47M
-8.02M
-7.18M
-2.62M
481.00K
-476.00K
2.01M
-2.18M
1.14M
3.45M
4.83M
Leverage & Debt
Debt to Equity
-1.08
-1.09
-1.10
-1.85
24.21
-5.16
2.96
-1.67
6.30
0.99
0.29
Interest Coverage TTM
-214.70
-272.90
-326.55
-2,307.60
-
-
-
-
-
-
-
Debt Ratio
13.53
12.60
10.60
2.18
0.96
1.24
0.75
2.48
0.86
0.50
0.23
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-0.93
-1.31
-1.48
-1.36
-1.37
-1.16
-1.20
-1.20
-1.40
-1.38
-1.42
Free Cash Flow Per Share TTM
-0.04
-0.12
-0.95
-1.54
-1.47
-1.05
-3.27
-10.05
-15.43
-16.78
-15.89
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
-12.12%
6.33%
6.21%
-31.32%
-38.46%
-36.94%
-31.81%
-11.53%
15.94%
18.93%
35.50%
EPS Growth (1Y)
-83.06%
-73.97%
-38.18%
-81.12%
-87.75%
-89.49%
-83.17%
-45.58%
-11.71%
-15.35%
21.88%
Valuation Metrics
P/E TTM
-0.26
-0.20
-0.11
-0.13
-0.84
-0.78
-0.83
-0.57
-0.82
-0.67
-2.50
P/B
-0.26
-0.28
-0.20
-0.46
54.26
-11.57
7.49
-3.05
29.92
4.42
8.43
Market Cap
2.24M
2.22M
1.41M
1.20M
8.36M
8.24M
9.67M
8.00M
13.19M
11.17M
42.51M
Enterprise Value
2.74M
2.67M
1.83M
1.34M
7.18M
7.67M
5.67M
7.81M
12.14M
8.81M
39.06M
Calculated Values
Free Cash Flow TTM
-1.63M
-4.48M
-7.91M
-10.85M
-10.58M
-9.51M
-15.80M
-19.51M
-22.13M
-25.31M
-18.97M
Net Debt
499.00K
452.00K
422.00K
139.00K
-1.17M
-562.00K
-4.01M
-188.00K
-1.05M
-2.35M
-3.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2019-01-18Sale
Owner: Armistice, Capital, Llc, …
Title: -
Shares: 64,457
Price/Share: $2.66
Value: $171,455.62
Shares Owned: 129,298
Relationship: TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2025-03-31
0.44%
Inst. Shares: 31,127
Shares Outstanding: 7,062,000
2024-12-31
4.43%
Inst. Shares: 319,063
Shares Outstanding: 7,203,000
2024-09-30
0.52%
Inst. Shares: 46,735
Shares Outstanding: 9,051,000
2024-06-30
2.66%
Inst. Shares: 128,562
Shares Outstanding: 4,836,000
2024-03-31
0.98%
Inst. Shares: 19,067
Shares Outstanding: 1,941,000

Research Faster.
Invest Smarter.

BIO-PATH HOLDINGS, INC. (BPTH) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.